Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271

1.

Quantifying bee assemblages and attractiveness of flowering woody landscape plants for urban pollinator conservation.

Mach BM, Potter DA.

PLoS One. 2018 Dec 26;13(12):e0208428. doi: 10.1371/journal.pone.0208428. eCollection 2018.

2.

Un allié de poids.

Bialas MM, Buclin CP, Lataste-Munter O, Litzler C, Mach BA, Saudan M, Cosson P, Perrin J.

Rev Med Suisse. 2017 Dec 13;13(587):2190-2191. French. No abstract available.

PMID:
29239541
3.

Uptake and dissipation of neonicotinoid residues in nectar and foliage of systemically treated woody landscape plants.

Mach BM, Bondarenko S, Potter DA.

Environ Toxicol Chem. 2018 Mar;37(3):860-870. doi: 10.1002/etc.4021. Epub 2017 Dec 30.

PMID:
29080359
4.

SunMed, LLC, bougies.

Mach B.

Anesth Analg. 2011 Aug;113(2):430-1. No abstract available.

PMID:
21905312
5.

Nomenclature for factors of the HLA system, 2010.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Fernández-Viña M, Geraghty DE, Holdsworth R, Hurley CK, Lau M, Lee KW, Mach B, Maiers M, Mayr WR, Müller CR, Parham P, Petersdorf EW, Sasazuki T, Strominger JL, Svejgaard A, Terasaki PI, Tiercy JM, Trowsdale J.

Tissue Antigens. 2010 Apr;75(4):291-455. doi: 10.1111/j.1399-0039.2010.01466.x. Review. No abstract available.

6.

An update to HLA nomenclature, 2010.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Fernández-Viña M, Geraghty DE, Holdsworth R, Hurley CK, Lau M, Lee KW, Mach B, Maiers M, Mayr WR, Müller CR, Parham P, Petersdorf EW, Sasazuki T, Strominger JL, Svejgaard A, Terasaki PI, Tiercy JM, Trowsdale J.

Bone Marrow Transplant. 2010 May;45(5):846-8. doi: 10.1038/bmt.2010.79. Epub 2010 Mar 29.

PMID:
20348972
7.

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). 1993.

Steimle V, Otten LA, Zufferey M, Mach B.

J Immunol. 2007 Jun 1;178(11):6677-88. No abstract available.

8.

Nomenclature for Factors of the HLA System, 2004.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J.

Hum Immunol. 2005 May;66(5):571-636. Epub 2005 Mar 3. No abstract available.

PMID:
15935895
9.

Nomenclature for factors of the HLA system, 2004.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J.

Tissue Antigens. 2005 Apr;65(4):301-69. No abstract available.

PMID:
15787720
10.

Nomenclature for factors of the HLA system, 2004.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J.

Int J Immunogenet. 2005 Apr;32(2):107-59. No abstract available.

PMID:
15787643
11.

Nomenclature for factors of the HLA system, 2002.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf E, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Tissue Antigens. 2002 Nov;60(5):407-64. No abstract available.

PMID:
12492818
12.

Nomenclature for factors of the HLA system, 2002.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Hum Immunol. 2002 Dec;63(12):1213-68. No abstract available.

PMID:
12480266
13.

Nomenclature for factors of the HLA system, 2002.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Eur J Immunogenet. 2002 Dec;29(6):463-515. No abstract available.

PMID:
12437610
14.

Nomenclature for factors of the HLA system, 2000.

Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, MacH B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Eur J Immunogenet. 2001 Jun;28(3):377-424. No abstract available.

PMID:
11422419
15.

Nomenclature for factors of the HLA system, 2000.

Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Hum Immunol. 2001 Apr;62(4):419-68. No abstract available.

PMID:
11295476
16.

Nomenclature for factors of the HLA system, 2000.

Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Tissue Antigens. 2001 Mar;57(3):236-83. No abstract available.

PMID:
11285132
17.

The bare lymphocyte syndrome and the regulation of MHC expression.

Reith W, Mach B.

Annu Rev Immunol. 2001;19:331-73. Review.

PMID:
11244040
18.

Dendritic cells and differential usage of the MHC class II transactivator promoters in the central nervous system in experimental autoimmune encephalitis.

Suter T, Malipiero U, Otten L, Ludewig B, Muelethaler-Mottet A, Mach B, Reith W, Fontana A.

Eur J Immunol. 2000 Mar;30(3):794-802.

19.

Structure of the winged-helix protein hRFX1 reveals a new mode of DNA binding.

Gajiwala KS, Chen H, Cornille F, Roques BP, Reith W, Mach B, Burley SK.

Nature. 2000 Feb 24;403(6772):916-21.

PMID:
10706293
20.

The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression.

Reith W, Muhlethaler-Mottet A, Masternak K, Villard J, Mach B.

Microbes Infect. 1999 Sep;1(11):839-46. Review. No abstract available.

PMID:
10614000
21.

Nomenclature for factors of the HLA system, 1998.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Vox Sang. 1999;77(3):164-91. No abstract available.

PMID:
10545854
22.

Perspectives: immunology. Regulating the regulator.

Mach B.

Science. 1999 Aug 27;285(5432):1367. No abstract available.

PMID:
10490413
23.
24.

Nomenclature for factors of the HLA System, 1998.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Hum Immunol. 1999 Apr;60(4):361-95. No abstract available.

PMID:
10363728
25.

Nomenclature for factors of the HLA system, 1998.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Eur J Immunogenet. 1999 Apr-Jun;26(2-3):81-116. No abstract available.

PMID:
10331156
26.
27.

Nomenclature for factors of the HLA system, 1998.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Tissue Antigens. 1999 Apr;53(4 Pt 2):407-46. No abstract available.

PMID:
10321590
28.

CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.

Villard J, Muhlethaler-Mottet A, Bontron S, Mach B, Reith W.

Int Immunol. 1999 Mar;11(3):461-9.

PMID:
10221658
29.

A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.

Masternak K, Barras E, Zufferey M, Conrad B, Corthals G, Aebersold R, Sanchez JC, Hochstrasser DF, Mach B, Reith W.

Nat Genet. 1998 Nov;20(3):273-7.

PMID:
9806546
30.

[Aviation fuels and aircraft emissions. A risk characterization for airport neighbors using Hamburg Airport as an example].

Tesseraux I, Mach B, Koss G.

Zentralbl Hyg Umweltmed. 1998 Jun;201(2):135-51. Review. German.

PMID:
9686444
31.

Zinc deficiency in exclusively breast-fed infants.

Piela Z, Szuber M, Mach B, Janniger CK.

Cutis. 1998 Apr;61(4):197-200.

PMID:
9564591
32.

DNA binding properties of a chemically synthesized DNA binding domain of hRFX1.

Cornille F, Emery P, Schüler W, Lenoir C, Mach B, Roques BP, Reith W.

Nucleic Acids Res. 1998 May 1;26(9):2143-9.

33.

Genetic and molecular definition of complementation group D in MHC class II deficiency.

Fondaneche MC, Villard J, Wiszniewski W, Jouanguy E, Etzioni A, Le Deist F, Peijnenburg A, Casanova JL, Reith W, Mach B, Fischer A, Lisowska-Grospierre B.

Hum Mol Genet. 1998 May;7(5):879-85.

PMID:
9536093
34.

Quantitative control of MHC class II expression by the transactivator CIITA.

Otten LA, Steimle V, Bontron S, Mach B.

Eur J Immunol. 1998 Feb;28(2):473-8.

35.
36.

Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice.

Clausen BE, Waldburger JM, Schwenk F, Barras E, Mach B, Rajewsky K, Förster I, Reith W.

Immunity. 1998 Feb;8(2):143-55.

37.

[Genetic genius and medicine].

Mach B.

Rev Med Suisse Romande. 1997 Dec;117(12):925-6. French. No abstract available.

PMID:
9481162
38.

MHC class II deficiency: definition of a new complementation group.

Villard J, Mach B, Reith W.

Immunobiology. 1997 Dec;198(1-3):264-72. Review.

PMID:
9442397
39.

Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.

Villard J, Lisowska-Grospierre B, van den Elsen P, Fischer A, Reith W, Mach B.

N Engl J Med. 1997 Sep 11;337(11):748-53.

41.

Correction of defective expression in MHC class II deficiency (bare lymphocyte syndrome) cells by retroviral transduction of CIITA.

Bradley MB, Fernandez JM, Ungers G, Diaz-Barrientos T, Steimle V, Mach B, O'Reilly R, Lee JS.

J Immunol. 1997 Aug 1;159(3):1086-95.

PMID:
9233601
42.

A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes.

Conrad B, Weissmahr RN, Böni J, Arcari R, Schüpbach J, Mach B.

Cell. 1997 Jul 25;90(2):303-13.

44.

Nomenclature for factors of the HLA system, 1996.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Eur J Immunogenet. 1997 Apr;24(2):105-51. No abstract available.

PMID:
9104581
45.
46.

RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.

Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W.

EMBO J. 1997 Mar 3;16(5):1045-55.

47.

Nomenclature for factors of the HLA System, 1996.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Hum Immunol. 1997 Mar;53(1):98-128. Review. No abstract available.

PMID:
9127153
48.

Nomenclature for factors of the HLA system, 1996.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Tissue Antigens. 1997 Mar;49(3 Pt 2):297-321. No abstract available.

PMID:
9098945
49.

Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency.

Villard J, Reith W, Barras E, Gos A, Morris MA, Antonarakis SE, Van den Elsen PJ, Mach B.

Hum Mutat. 1997;10(6):430-5.

PMID:
9401005
50.

Nomenclature for factors of the HLA system, 1996.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Vox Sang. 1997;73(2):105-30. No abstract available.

PMID:
9304780

Supplemental Content

Support Center